Nektar Therapeutics | NKTR - Ebit


Nektar Therapeutics reported $-38.26M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Agios Pharmaceuticals USD -110.55M 527K Jun/2026
ALKERMES USD 36.59M 102.52M Sep/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 4.68B 65M Sep/2026
Baxter International USD 314M 38M Sep/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
Biogen USD 419.5M 663.3M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Cara Therapeutics USD -7.05M 1.11M Mar/2026
Cipla INR 10.43B 1.55B Sep/2026
Dr.Reddys Laboratories INR 12.16B 8.91B Sep/2026
Eisai JPY 16.7B 8.03B Sep/2026
Eli Lilly USD 13.09B 635M Sep/2026
Exelixis USD 268.42M 20.01M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -60.68M 3.04M Sep/2026
Incyte USD -707.47M 1.41B Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
MacroGenics USD -65.25M 33.36M Jun/2026
Merck USD 7.33B 6.49B Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Neurocrine Biosciences USD 343M 123.1M Sep/2026
Novartis USD 5.14B 411M Sep/2026
Pfizer USD 4.85B 5.03B Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sarepta Therapeutics USD -9.04M 22.33M Sep/2026
Takeda JPY 205.32B 3.9B Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
Xencor USD -36.6M 41.26M Jun/2026